Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 6, 2005, Pages 453-458

  Marlière, Stéphanie ^a   Cracowski, Jean Luc ^a   Hakim, Ahmed ^a   Stanke Labesque, Françoise ^a   Hoffmann, Pascale ^a   Bessard, Germain ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Hypertension; Isoprostane; Lipid peroxidation; Vascular reactivity

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ENALAPRIL MALEATE; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; PROSTAGLANDIN H2 RECEPTOR; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; VAPIPROST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR UPREGULATION; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; CYCLOOXYGENASE INHIBITORS; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; ENDOTHELIUM, VASCULAR; HYPERTENSION; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; VASOCONSTRICTOR AGENTS;

EID: 23844504611     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-027     Document Type: Article

References (34)

1. Antonaccio, M.J., Rubin, B., and Kotler, D. 1981. Effects of captopril on vascular reactivity of SHR in vivo and in vitro. Hypertension, 3: II-211-II-215.
2. Auch-Schwelk, W., Katusic, Z.S., and Vanhoutte, P.M. 1989. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension, 13: 859-864.
3. Cheng, Z.J., Vaskonen, T., Tikkanen, I., Nurminen, K., Ruskoaho, H., Vapaatalo, H., Muller, D., Park, J.K., Luft, F.C., and Mervaala, E.M. 2001. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension, 37: 433-439.
4. Clozel, M., Kuhn, H., and Hefti, F. 1990. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension, 16: 532-540.
5. 2 on some isolated smooth muscle preparations. Br. J. Pharmacol. 73: 773-778.
6. Coleman, R.A., Smith, W.L., and Narumiya, S. 1994. Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-209.
7. Cracowski, J.L., Devillier, P., Durand, T., Stanke-Labesque, K., and Bessard, G. 2001. Vascular biology of the isoprostanes. J. Vasc. Res. 38: 93-103.
8. Cracowski, J.L., Durand, T., and Bessard, G. 2002. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol. Sci. 23: 360-366.
9. Cracowski, J.L., Baguet, J.P., Ormezzano, O., Bessard, J., Stanke-Labesque, R., Bessard, G., and Million, J.M. 2003. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension, 41: 286-288.
10. Cryer, B., and Feldman, M. 1998. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med. 104: 413-421.
11. Dobrian, A.D., Davies, M.J., Schriver, S.D., Lauterio, T.J., and Prewitt, R.L. 2001. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension, 37: 554-560.
12. Garcia-Cohen, E.C., Marin, J., Diez-Picazo, L.D., Baena, A.B., Salaices, M., and Rodriguez-Martinez, M.A. 2000. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform. J. Pharmacol. Exp. Ther. 293: 75-81.
13. Hibino, M., Okumura, K., Iwama, Y., Mokuno, S., Osanai, H., Matsui, H., Toki, Y., and Ito, T. 1999. Oxygen-derived free radical-induced vasoconstriction by thromboxane A2 in aorta of the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 33: 605-610.
14. Janssen, L.J., Premji, M., Netherton, S., Catalli, A., Cox, G., Keshavjee, S., and Crankshaw, D.J. 2000. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle. J. Pharmacol. Exp. Ther. 295: 506-511.
15. Janssen, L.J., Premji, M., Netherton, S., Coruzzi, J., Lu-Chao, H., and Cox, P.G. 2001. Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. Br. J. Pharmacol. 132: 127-134.
16. 2α in rat pulmonary artery. Br. J. Pharmacol. 120: 1280-1285.
17. 2α on isolated rat aorta. J. Cardiovasc. Pharmacol. 32: 471-478.
18. Lerman, L.O., Nath, K.A., Rodriguez-Porcel, M., Krier, J.D., Schwartz, R.S., Napoli, C., and Romero, J.C. 2001. Increased oxidative stress in experimental renovascular hypertension. Hypertension, 37: 541-546.
19. 2-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein. Br. J. Pharmacol. 135: 1276-1280.
20. McIntyre, M., Bohr, D.F., and Dominiczak, A.F. 1999. Endothelial function in hypertension: the role of superoxide anion. Hypertension, 34: 539-545.
21. Mervaala, E.M., Cheng, Z.J., Tikkanen, I., Lapatto, R., Nurminen, K., Vapaatalo, H., Muller, D.N., Fiebeler, A., Ganten, U., Ganten, D., and Luft, F.C. 2001. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension, 37: 414-418.
22. Minuz, P., Patrignani, P., Gaino, S., Degan, M., Menapace, L., Tommasoli, R. et al. 2002. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation, 106: 2800-2805.
23. Moncada, S., Higgs, A., and Furchgott, R. 1997. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol. Rev. 49: 137-142.
24. Morrow, J., Awad, J., Boss, H., Blair, I., and Roberts, L. II. 1992. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. U.S.A. 89: 10721-10725.
25. Ortiz, M.C., Sanabria, E., Manriquez, M.C., Romero, J.C., and Juncos, L.A. 2001. Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension, 37: 505-510.
26. Reckelhoff, J.F., Zhang, H., Srivastava, K., Roberts, L.J. II, Morrow, J.D., and Romero, J.C. 2000. Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats. Hypertension, 35: 476-479.
27. Rodrigo, E., Maeso, R., Munoz-Garcia, R., Navarro-Cid, J., Ruilope, L.M., Cachofeiro, V., and Lahera, V. 1997. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J. Hypertens. 15: 613-618.
28. Schnackenberg, G.G., Welch, W.J., and Wilcox, C.S. 1998. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension, 32: 59-64.
29. Stanke-Labesque, F., Devillier, P., Veitl, S., Caron, F., Cracowski, J., and Bessard, G. 2001. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats. Cardiovasc. Res. 49: 152-160.
30. Suzuki, H., Swei, A., Zweifach, B.W., and Schmid-Schonbein, G.W. 1995. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hypertension, 25: 1083-1089.
31. Suzuki, H., DeLano, F.A., Parks, D.A., Jamshidi, N., Granger, D.N., Ishii, H., Suematsu, M., Zweifach, B.W., and Schmid-Schonbein, G.W. 1998. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. U.S.A. 95: 4754-4759.
32. 2α in rat aortic rings. Prostaglandins, 54: 581-599.
33. 2α, in experimental hypercholesterolemia. Cardiovasc. Res. 44: 601-607.
34. Zalba, G., Beaumont, F.J., San Jose, G., Fortuno, A., Fortuno, M.A., Etayo, J.C., and Diez, J. 2000. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension, 35: 1055-1061.